Page 8 - Kineta Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kineta inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kineta Inc Today - Breaking & Trending Today

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Thierry Guillaudeux , Kineta Inc , Jacques Bouchyevp Investor Relations Business Development , John Mullalylifesci Advisors , Annual Macrophage Directed Therapies Summit , Chief Scientific Officer , Engineered Igg , Combination With Pembrolizumab , Advanced Solid Tumorspresenter , Business Development ,

Kineta (NASDAQ:KA) Announces Quarterly Earnings Results

Kineta (NASDAQ:KA – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.46) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.09, reports. Kineta Stock Up 5.7 % Shares of KA traded up $0.24 during trading hours on Monday, hitting $4.42. 44,832 shares of the […] ....

Blackrock Inc , Kineta Inc , Colony Group , Asset Management Inc , Renaissance Technologies , Geode Capital Management , Get Free Report , Capital Management , Management Inc , Kineta Daily , Nasdaq Ka ,

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shawn Iadonato , Thierry Guillaudeux , Jacques Bouchyevp Investor Relations Business Development , Society For Immunotherapy Of Cancer , Kineta Inc , San Diego Convention Center , John Mullalylifesci Advisors , Favorable Clinical Safety , Tolerability Profile Observed , Combination Therapy Clinical Data Anticipated , Chief Scientific Officer , Chief Executive Officer , Abstract Number , Time Location , Exhibit Halls , Diego Convention , Statements Regarding Forward Looking , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Business Development ,

Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Shawn Iadonato , Jacques Bouchy , John Mullaly , Society For Immunotherapy Of Cancer , Research Collaboration Agreement , Kineta Inc , Fred Hutchinson Cancer Center , Slab Program , Lifesci Advisors , Investor Relations Business Development , Reports Third Quarter , Provides Corporate , Cash Runway , Chief Executive Officer , Guillaudeux Phd , Chief Scientific Officer , Merck Exclusive License , Genentech Option , License Agreement , Statements Regarding Forward Looking , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Months Ended September , Business Development , Sci Advisors ,

Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jacques Bouchy , Thierry Guillaudeux , John Mullaly , Society For Immunotherapy Of Cancer , Lifesci Advisors , Kineta Inc , San Diego Convention Center , Investor Relations Business Development , Presents New Preclinical Data , Antibody Showed High Binding Affinity , Strongt Cell Activation , Vivo Antitumor Efficacy , Single Agent , Checkpoint Inhibitors , Hematological Tumor , Chief Scientific Officer , Exhibit Halls , San Diego Convention , Statements Regarding Forward Looking , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Business Development , Sci Advisors ,